Case File 01 · Reproductive & Inflammatory
Five years of amenorrhea, in a patient already labelled with PCOS
The dominant baseline signal was not insulin. When prolactin and systemic inflammation dominate the picture, the original diagnosis is worth revisiting before the protocol is written.
History & Presentation
Starting symptoms
The patient presented with chronic fatigue, weight dysregulation, impaired metabolic health and reduced functional capacity, alongside five years of absent menstrual cycles. She carried a standing PCOS diagnosis and had previously trialled oral contraceptives and metformin without cycle restoration.
Baseline Markers
What the panel showed
| Marker | Baseline | Read |
|---|---|---|
| hs-CRP | 16.62 mg/L | Elevated |
| ESR | 85 mm/hr | Elevated |
| WBC | 12.02 ×10³/µL | Elevated |
| Prolactin | 39.1 ng/mL | Elevated |
| Morning cortisol | 39.8 µg/dL | Monitor |
| Estradiol | 13 pg/mL | Low |
| Progesterone | 0.8 ng/mL | Anovulatory |
| LH:FSH ratio | ~2.9 | Monitor |
| Fasting insulin | 18.28 µIU/mL | Elevated |
| Ferritin | 49.3 ng/mL | Average |
| Iron / TSAT | 37 µg/dL / 8% | Low |
| Vitamin D | Insufficient | Monitor |
Pattern Identified
"The dominant baseline signal was not insulin alone." Marked inflammatory elevation, alongside hyperprolactinemia and low reproductive hormones, pointed toward a picture broader than metabolic PCOS.
Strategic Priority
Reassess the diagnosis, not just the metabolism
Rather than defaulting to an insulin-resistance-first PCOS protocol, the strategy questioned whether the original diagnosis explained the full presentation, given the competing signals of elevated prolactin and systemic inflammation running alongside the reproductive dysfunction.
Implementation · 8 Weeks
What was implemented
Inflammatory-load reduction
- Removal of selected dietary triggers
- Reduced refined sugar intake
- Anti-inflammatory nutrient support
- Gut-directed interventions
Sleep & autonomic regulation
- Sleep-hygiene protocols
- Twice-daily vagal practices
- Stress modulation techniques
- Magnesium and glycine supplementation
Metabolic stabilization
- Protein-first framework: 100-120 g/day target
- Glycemic regulation strategies
- Berberine-based support
- Progressive resistance training and movement
Nutritional repletion
- Iron supplementation
- Vitamin D repletion
- B-vitamin support
Objective Progress · Week 8
What moved
| Marker | Baseline | Week 8 | Change |
|---|---|---|---|
| hs-CRP | 16.62 mg/L | 4.5 mg/L | −72.9% |
| ESR | 85 mm/hr | 11 mm/hr | −87.1% |
| Prolactin | 39.1 ng/mL | 8.97 ng/mL | −77.1% |
| WBC | 12.02 ×10³/µL | 10.4 ×10³/µL | Normalized |
| Weight | - | 72 kg | −~8 kg |
| Fasting insulin | 18.28 µIU/mL | 29.70 µIU/mL | +62.4% |
Key dissociation: menstrual function recovered while fasting insulin remained elevated, and rose further.
Subjective Progress
- Spontaneous menstrual bleeding returned
- Improved sleep quality and consistency
- Enhanced energy and daily functional capacity
- Better overall sense of wellbeing
What Changed Next
Reproductive recovery occurred before metabolic normalization, challenging an insulin-resistance-first model of PCOS management. Prolonged amenorrhea in a patient labelled with PCOS warrants renewed evaluation whenever prolactin, inflammatory markers, or other competing signals are abnormal.
Limitations
Documented Limitations
- Single case with multiple concurrent interventions, so causality cannot be isolated to any one component.
- Original PCOS diagnostic criteria and ovarian imaging were not available for this review.
- No documented complete exclusion work-up for alternative diagnoses.
- Returned bleeding was not confirmed as ovulatory. That would require progesterone testing, cycle tracking, or ultrasound.
- Long-term cycle regularity beyond the observation window is not reported.